+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Telemedicine Technologies and Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

  • PDF Icon

    Report

  • 354 Pages
  • June 2022
  • Region: Global
  • Transparency Market Research
  • ID: 5641276
This report on the global telemedicine technologies and services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global telemedicine technologies and services market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global telemedicine technologies and services market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the telemedicine technologies and services market.

Secondary research also Incuded Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global telemedicine technologies and services market.

The report Incudes an elaborate executive summary, along with a snapshot of the growth behavior of various segments Incuded in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global telemedicine technologies and services market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global telemedicine technologies and services market.

The report delves into the competitive landscape of the global telemedicine technologies and services market. Key players operating in the global telemedicine technologies and services market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global telemedicine technologies and services market profiled in this report.

Research Methodology:

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market telemedicine technologies and services.

Secondary Research:

Secondary research Incudes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

  • Company websites, presentations, annual reports, white papers, technical paper, product brochure
  • Internal and external proprietary databases and relevant patents
  • National government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:

  • WorldWideScience.org
  • Elsevier, Inc
  • National Institutes of Health (NIH)
  • PubMed
  • NCBI
  • Department of Health Care Service

Trade Data Sources:

  • Trade Map
  • UN Comtrade
  • Trade Atlas

Company Information:

  • OneSource Business Browser
  • Hoover’s
  • Factiva
  • Bloomberg

Mergers & Acquisitions:

  • Thomson Mergers & Acquisitions
  • MergerStat
  • Profound

Primary Research:

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

The publisher conducts primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis.

A typical research interview fulfills the following functions:

  • Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc
  • Helps in validating and strengthening secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process Incude, but are not limited to:

  • Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
  • Purchasing/Sourcing managers, technical personnel, distributors
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • Hitachi, Ltd
  • IBA Worldwide
  • Mevion Medical Systems, Inc
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with the publisher's 'Knowledge Repository', which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets.

A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

  • Demographic Data: Healthcare expenditure, inflation rates, and others
  • Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology3. Executive Summary: Global Telemedicine Technologies and Services Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Telemedicine Technologies and Services Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Technological Advancements
5.2. Reimbursement Scenario by Region/globally
5.3. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Telemedicine Technologies and Services Market Analysis and Forecast, By Component
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Component, 2017-2031
6.3.1. Hardware
6.3.2. Software
6.3.3. Services
6.4. Market Attractiveness By Component
7. Global Telemedicine Technologies and Services Market Analysis and Forecast, By Specialty
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Specialty, 2017-2031
7.3.1. Dermatology
7.3.2. Gynecology
7.3.3. Neurology
7.3.4. Cardiology
7.3.5. Orthopedics
7.3.6. Emergency care
7.3.7. Internal Medicine
7.3.8. Others
7.4. Market Attractiveness Analysis, By Specialty
8. Global Telemedicine Technologies and Services Market Analysis and Forecast, By Services
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Services, 2017-2031
8.3.1. Tele-consultation
8.3.2. Tele-monitoring
8.3.3. Tele-education
8.3.4. Tele-training
8.3.5. Tele-care
8.3.6. Telesurgery
8.3.7. Others
8.4. Market Attractiveness Analysis, By Services
9. Global Telemedicine Technologies and Services Market Analysis and Forecast, By Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, By Region
10. North America Telemedicine Technologies and Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Component, 2017-2031
10.2.1. Hardware
10.2.2. Software
10.2.3. Services
10.3. Market Value Forecast, by Specialty, 2017-2031
10.3.1. Dermatology
10.3.2. Gynecology
10.3.3. Neurology
10.3.4. Cardiology
10.3.5. Orthopedics
10.3.6. Emergency care
10.3.7. Internal Medicine
10.3.8. Others
10.4. Market Value Forecast, by Services, 2017-2031
10.4.1. Tele-consultation
10.4.2. Tele-monitoring
10.4.3. Tele-education
10.4.4. Tele-training
10.4.5. Tele-care
10.4.6. Telesurgery
10.4.7. Others
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Component
10.6.2. By Specialty
10.6.3. By Services
10.6.4. By Country
11. Europe Telemedicine Technologies and Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Component, 2017-2031
11.2.1. Hardware
11.2.2. Software
11.2.3. Services
11.3. Market Value Forecast, by Specialty, 2017-2031
11.3.1. Dermatology
11.3.2. Gynecology
11.3.3. Neurology
11.3.4. Cardiology
11.3.5. Orthopedics
11.3.6. Emergency care
11.3.7. Internal Medicine
11.3.8. Others
11.4. Market Value Forecast, by Services, 2017-2031
11.4.1. Tele-consultation
11.4.2. Tele-monitoring
11.4.3. Tele-education
11.4.4. Tele-training
11.4.5. Tele-care
11.4.6. Telesurgery
11.4.7. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Component
11.6.2. By Specialty
11.6.3. By Services
11.6.4. By Country/Sub-region
12. Asia Pacific Telemedicine Technologies and Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Component, 2017-2031
12.2.1. Hardware
12.2.2. Software
12.2.3. Services
12.3. Market Value Forecast, by Specialty, 2017-2031
12.3.1. Dermatology
12.3.2. Gynecology
12.3.3. Neurology
12.3.4. Cardiology
12.3.5. Orthopedics
12.3.6. Emergency care
12.3.7. Internal Medicine
12.3.8. Others
12.4. Market Value Forecast, by Services, 2017-2031
12.4.1. Tele-consultation
12.4.2. Tele-monitoring
12.4.3. Tele-education
12.4.4. Tele-training
12.4.5. Tele-care
12.4.6. Telesurgery
12.4.7. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Component
12.6.2. By Specialty
12.6.3. By Services
12.6.4. By Country/Sub-region
13. Latin America Telemedicine Technologies and Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Component, 2017-2031
13.2.1. Hardware
13.2.2. Software
13.2.3. Services
13.3. Market Value Forecast, by Specialty, 2017-2031
13.3.1. Dermatology
13.3.2. Gynecology
13.3.3. Neurology
13.3.4. Cardiology
13.3.5. Orthopedics
13.3.6. Emergency care
13.3.7. Internal Medicine
13.3.8. Others
13.4. Market Value Forecast, by Services, 2017-2031
13.4.1. Tele-consultation
13.4.2. Tele-monitoring
13.4.3. Tele-education
13.4.4. Tele-training
13.4.5. Tele-care
13.4.6. Telesurgery
13.4.7. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Component
13.6.2. By Specialty
13.6.3. By Services
13.6.4. By Country/Sub-region
14. Middle East & Africa Telemedicine Technologies and Services Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Component, 2017-2031
14.2.1. Hardware
14.2.2. Software
14.2.3. Services
14.3. Market Value Forecast, by Specialty, 2017-2031
14.3.1. Dermatology
14.3.2. Gynecology
14.3.3. Neurology
14.3.4. Cardiology
14.3.5. Orthopedics
14.3.6. Emergency care
14.3.7. Internal Medicine
14.3.8. Others
14.4. Market Value Forecast, by Services, 2017-2031
14.4.1. Tele-consultation
14.4.2. Tele-monitoring
14.4.3. Tele-education
14.4.4. Tele-training
14.4.5. Tele-care
14.4.6. Telesurgery
14.4.7. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Component
14.6.2. By Specialty
14.6.3. By Services
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. McKesson Corporation
15.2.1.1. Overview (HQ, Employee Strength, Business Segments)
15.2.1.2. Financials
15.2.1.3. Recent Developments
15.2.1.4. Strategy
15.2.2. F. Hoffmann-La Roche Ltd.
15.2.2.1. Overview (HQ, Employee Strength, Business Segments)
15.2.2.2. Financials
15.2.2.3. Recent Developments
15.2.2.4. Strategy
15.2.3. Medtronic
15.2.3.1. Overview (HQ, Employee Strength, Business Segments)
15.2.3.2. Financials
15.2.3.3. Recent Developments
15.2.3.4. Strategy
15.2.4. Koninklijke Philips N.V.
15.2.4.1. Overview (HQ, Employee Strength, Business Segments)
15.2.4.2. Financials
15.2.4.3. Recent Developments
15.2.4.4. Strategy
15.2.5. GE Healthcare
15.2.5.1. Overview (HQ, Employee Strength, Business Segments)
15.2.5.2. Financials
15.2.5.3. Recent Developments
15.2.5.4. Strategy
15.2.6. LifeWatch
15.2.6.1. Overview (HQ, Employee Strength, Business Segments)
15.2.6.2. Financials
15.2.6.3. Recent Developments
15.2.6.4. Strategy
15.2.7. Honeywell International, Inc.
15.2.7.1. Overview (HQ, Employee Strength, Business Segments)
15.2.7.2. Financials
15.2.7.3. Recent Developments
15.2.7.4. Strategy
15.2.8. AMD Global Telemedicine, Inc.
15.2.8.1. Overview (HQ, Employee Strength, Business Segments)
15.2.8.2. Financials
15.2.8.3. Recent Developments
15.2.8.4. Strategy
15.2.9. GlobalMed
15.2.9.1. Overview (HQ, Employee Strength, Business Segments)
15.2.9.2. Financials
15.2.9.3. Recent Developments
15.2.9.4. Strategy
15.2.10. Aerotel Medical Systems Ltd.
15.2.10.1. Overview (HQ, Employee Strength, Business Segments)
15.2.10.2. Financials
15.2.10.3. Recent Developments
15.2.10.4. Strategy

Companies Mentioned

A selection of companies mentioned in this report includes:

  • McKesson Corporation
  • F. Hoffmann-La Roche Ltd.
  • Medtronic
  • Koninklijke Philips N.V.
  • GE Healthcare
  • LifeWatch
  • Honeywell International, Inc.
  • AMD Global Telemedicine, Inc.
  • GlobalMed
  • Aerotel Medical Systems Ltd.